Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.

Abstract:

BACKGROUND:Model predictions of regional deposition in the respiratory tract are useful in assessing factors that influence the effectiveness of aerosol delivery. Regional deposition models have previously been coupled with models of mucous production and clearance to estimate initial concentrations of drug deposited in the airway surface liquid (ASL) lining tracheobronchial airways. METHODS:Established models of regional deposition and ASL volumes were used to provide input to a new model evaluating the disposition of drug resulting from dissolution or release, absorption, and mucociliary clearance. Additional modeling of oral absorption, distribution, and elimination allowed prediction of systemic exposure. Herein, predicted ASL and plasma concentrations of free (dissolved or unencapsulated) ciprofloxacin over time are reported for a healthy, adult lung model following inhalation of single doses of nebulized liposomal (6 mL of liposomal ciprofloxacin for inhalation, 50 mg/mL, or 6 mL of Pulmaquin, 210 mg; Aradigm) and dry powder (32.5 and 65 mg doses; Bayer) formulations. RESULTS:Over a range of mucous production rates and tracheal clearance velocities, peak ASL concentrations of free ciprofloxacin were consistently greater for Pulmaquin than for other formulations investigated, owing to the presence of free drug in the nebulized Pulmaquin formulation. The time that ASL concentrations of free drug remained above the minimum inhibitory concentration for Pseudomonas aeruginosa was similar for all four formulations. Predicted plasma ciprofloxacin concentration profiles were in good agreement with available data from Phase I trials in healthy volunteers. CONCLUSIONS:Predictions of ASL drug concentrations over time are valuable in elucidating the roles of deposition, drug release or dissolution, and disposition on the effectiveness of inhaled aerosol therapies. For inhaled ciprofloxacin, the present results predict similar ASL concentrations of free drug over time following single doses of inhaled liposomal and dry powder formulations. The impact of multiple doses and airway disease warrants further consideration.

authors

Martin AR,Finlay WH

doi

10.1089/jamp.2017.1377

subject

Has Abstract

pub_date

2018-02-01 00:00:00

pages

49-60

issue

1

eissn

1941-2711

issn

1941-2703

journal_volume

31

pub_type

杂志文章
  • Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform.

    abstract:: Background: Many substances used in inhalation research are water soluble and can be administered as nebulized solutions. Typical examples are therapeutic, small-molecular agents, or macromolecules. Another category is a number of water-soluble agents used for airway diagn...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2019.1554

    authors: Gerde P,Nowenwik M,Sjöberg CO,Selg E

    更新日期:2020-04-01 00:00:00

  • An Apparatus to Deliver Mannitol Powder for Bronchial Provocation in Children Under Six Years Old.

    abstract:BACKGROUND:Currently bronchial provocation testing (BPT) using mannitol powder cannot be performed in children under 6 years. A primary reason is it is challenging for children at this age to generate a consistent inspiratory effort to inhale mannitol efficiently from a dry powder inhaler. A prototype system, which doe...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1208

    authors: Tang P,Leung SS,Hor E,Ruzycki CA,Carrigy NB,Finlay WH,Brannan JD,Devadason S,Anderson SD,Sly PD,Samnick K,Chan HK

    更新日期:2015-12-01 00:00:00

  • Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients.

    abstract:BACKGROUND:To validate the 'Test of Adherence to Inhalers' (TAI), a 12-item questionnaire designed to assess the adherence to inhalers in patients with COPD or asthma. METHODS:A total of 1009 patients with asthma or COPD participated in a cross-sectional multicenter study. Patients with electronic adherence ≥80% were ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,多中心研究

    doi:10.1089/jamp.2015.1212

    authors: Plaza V,Fernández-Rodríguez C,Melero C,Cosío BG,Entrenas LM,de Llano LP,Gutiérrez-Pereyra F,Tarragona E,Palomino R,López-Viña A,TAI Study Group.

    更新日期:2016-04-01 00:00:00

  • Characterization of Medication Velocity and Size Distribution from Pressurized Metered-Dose Inhalers by Phase Doppler Anemometry.

    abstract:BACKGROUND:Particle size and velocity are two of the most significant factors that impact the deposition of pressurized metered-dose inhaler (pMDI) sprays in the mouth cavity. pMDIs are prominently used around the world in the treatment of patients suffering from a variety of lung diseases such as asthma and chronic ob...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1264

    authors: Alatrash A,Matida E

    更新日期:2016-12-01 00:00:00

  • Aerosol Therapy in Adults Receiving High Flow Nasal Cannula Oxygen Therapy.

    abstract:BACKGROUND:High flow nasal cannula oxygen therapy (HFT) is increasingly used in intensive and emergency care departments. Patients suffering from respiratory failure, who are likely to benefit from HFT, may require aerosolized bronchodilators; therefore, combining nebulization with HFT may be relevant. This study aimed...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1219

    authors: Réminiac F,Vecellio L,Heuzé-Vourc'h N,Petitcollin A,Respaud R,Cabrera M,Pennec DL,Diot P,Ehrmann S

    更新日期:2016-04-01 00:00:00

  • Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract.

    abstract:BACKGROUND:Small rodents continue to be the mainstay for the assessment of pharmacological and toxicological data of inhaled therapeutics. For meaningful interpretation of the results information about deposition of aerosol particles in the respiratory tract is warranted, but not trivial to obtain for animals with nose...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2011.0902

    authors: Ahmed A,Prime D,Burnell PK,Högger P

    更新日期:2012-06-01 00:00:00

  • Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse.

    abstract:BACKGROUND:Programmed cell death 4 (PDCD4), a protein that binds to eukaryotic initiation factor 4A (eIF4A), inhibits the initiation of translation. Although a number of tumor suppressors target transcription, Pdcd4 is the first suppressor targeting protein translation, and has also been suggested to function as a tumo...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2009.0778

    authors: Hwang SK,Minai-Tehrani A,Lim HT,Shin JY,An GH,Lee KH,Park KR,Kim YS,Beck GR Jr,Yang HS,Cho MH

    更新日期:2010-10-01 00:00:00

  • Vitamin A Supplementation by Endotracheal Application of a Nano-encapsulated Preparation Is Feasible in Ventilated Preterm Lambs.

    abstract:BACKGROUND:Vitamin A (VA) is crucial for lung growth and development. In premature infants, inadequate VA levels are associated with an increased risk of bronchopulmonary dysplasia (BPD). Intramuscular VA supplementation has been shown to decrease the incidence of BPD, but is not widely used in the clinical setting due...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1438

    authors: Wahl HB,Hütten MC,Monz D,Tutdibi E,Ophelders D,Nikiforou M,Tschernig T,Gortner L,Nohr D,Biesalski HK,Kramer BW

    更新日期:2018-12-01 00:00:00

  • Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex.

    abstract::Antibiotic-resistant bacterial infections have renewed interest in finding substitute methods of treatment. The purpose of the present in vitro study was to investigate the possibility of respiratory delivery of a Burkholderia cepacia complex (BCC) bacteriophage by nebulized aerosol administration. Bacteriophages in i...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0701

    authors: Golshahi L,Seed KD,Dennis JJ,Finlay WH

    更新日期:2008-12-01 00:00:00

  • Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.

    abstract:BACKGROUND:The Abbreviated Impactor Measurement (AIM) concept simplifies determination of aerodynamic size metrics for inhaler quality control testing. A similar approach is needed to compare in vitro particle size distribution metrics with human respiratory tract (HRT) deposition. METHODS:An abbreviated impactor base...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2011.0925

    authors: Mitchell J,Copley M,Sizer Y,Russell T,Solomon D

    更新日期:2012-08-01 00:00:00

  • Nebulized medications for the treatment of dyspnea: a literature review.

    abstract:BACKGROUND:Dyspnea significantly impacts quality of life and is one of the most common symptoms in advanced illness. Systemically-administered opioids and benzodiazepines have been the most studied and utilized pharmacologic treatments for refractory dyspnea. Less attention has been given to the use of these medication...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,评审

    doi:10.1089/jamp.2014.1136

    authors: Boyden JY,Connor SR,Otolorin L,Nathan SD,Fine PG,Davis MS,Muir JC

    更新日期:2015-02-01 00:00:00

  • Age-dependent deterioration of peak inspiratory flow with two kinds of dry powder corticosteroid inhalers (Diskus and Turbuhaler) and relationships with asthma control.

    abstract:BACKGROUND:Inhaled corticosteroid (ICS) therapy has improved the quality of life (QOL) for many asthmatics and reduced mortality rates associated with asthma. However, some patients do not obtain therapeutic benefit despite satisfactory adherence. OBJECTIVES:To determine whether asthmatic patients were using ICS devic...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2010.0868

    authors: Baba K,Tanaka H,Nishimura M,Yokoe N,Takahashi D,Yagi T,Yamaguchi E,Maeda Y,Muto T,Hasegawa T

    更新日期:2011-12-01 00:00:00

  • Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.

    abstract:BACKGROUND:Computer modeling is used to predict inhaled aerosol deposition in the lung based on definition of the aerosol characteristics and the breathing pattern and airway anatomy of the subject. Validation of the models is limited by the lack of detailed experimental data. Three-dimensional imaging provides an oppo...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2014.1191

    authors: Fleming J,Conway J,Majoral C,Katz I,Caillibotte G,Pichelin M,Montesantos S,Bennett M

    更新日期:2015-12-01 00:00:00

  • A Novel In-Line Delivery System to Administer Dry Powder Mannitol to Mechanically Ventilated Patients.

    abstract:BACKGROUND:Mechanically ventilated patients commonly suffer from ventilator-associated pneumonia, hypoxemia, and other lower respiratory tract infection as a result of pathogen colonization and poor sputum clearance. Consequently, there is a high rate of morbidity and mortality in these patients. Dry powder mannitol in...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2016.1320

    authors: Feng B,Tang P,Leung SS,Dhanani J,Chan HK

    更新日期:2017-04-01 00:00:00

  • Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.

    abstract:: Background: The photo reflection method (PRM) is used to measure light reflected from particles released from dry powder inhalers (DPIs). This simple method depicts time trajectories of released drugs; however, it underestimates the number of particles at high peak inhalat...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2020.1610

    authors: Kondo T,Hibino M,Tanigaki T,Tajiri S,Horiuchi S

    更新日期:2020-11-04 00:00:00

  • Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.

    abstract:BACKGROUND:Predicting local lung tissue pharmacodynamic (PD) responses of inhaled drugs is a longstanding challenge related to the lack of experimental techniques to determine local free drug concentrations. This has prompted the use of physiologically based pharmacokinetic (PBPK) modeling to potentially predict local ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1436

    authors: Boger E,Fridén M

    更新日期:2019-02-01 00:00:00

  • Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.

    abstract:BACKGROUND:The Respimat Soft Mist Inhaler is reported to generate an aerosol with low spray momentum and a small droplet size. However, the transport characteristics of the Respimat aerosol are not well understood. The objective of this study was to characterize the transport and deposition of an aerosol emitted from t...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0708

    authors: Worth Longest P,Hindle M

    更新日期:2009-06-01 00:00:00

  • The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.

    abstract:BACKGROUND:Inhaled alpha1-antitrypsin (AAT) is being developed for treatment of cystic fibrosis to protect the lungs from excessive free elastase. High drug costs mandate a very efficient aerosol system to deliver a high payload to the airways. The I-neb Adaptive Aerosol Delivery (AAD) System is a portable, electronic,...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2009.0793

    authors: Geller DE,Kesser KC

    更新日期:2010-04-01 00:00:00

  • The effects of training on inhaler technique and quality of life in patients with COPD.

    abstract:OBJECTIVES:This experimental study was conducted to determine the effects of training on inhaler technique and quality of life in patients with chronic obstructive pulmonary disease (COPD). METHODS:Among the patients who applied at the outpatient clinic of chest diseases between March 2009 and May 2010, a total of 69 ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/jamp.2012.1017

    authors: Göriş S,Taşci S,Elmali F

    更新日期:2013-12-01 00:00:00

  • Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.

    abstract:BACKGROUND:Understanding the regional partition of deposition of inhaled particles within the lung is important for improving targeted delivery of inhaled aerosolized drugs. One factor affecting regional deposition is gravity. As the lung deforms under its own weight, changes in lung volume, in airway geometries, and i...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2014.1189

    authors: Sá RC,Zeman KL,Bennett WD,Prisk GK,Darquenne C

    更新日期:2015-12-01 00:00:00

  • In vitro characterization of the OptiChamber Diamond valved holding chamber.

    abstract:BACKGROUND:Use of a valved holding chamber (VHC) in conjunction with a pressurized metered dose inhaler (pMDI) can reduce issues relating to poor actuation-inhalation coordination and potentially improve the lung deposition of aerosol, compared with use of a pMDI alone. However, the performance of a VHC is influenced b...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2013.1067

    authors: Hatley RH,von Hollen D,Sandell D,Slator L

    更新日期:2014-08-01 00:00:00

  • Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.

    abstract:BACKGROUND:The delivery of antitubercular drugs through direct lung targeting can lead to reduction in the dose as well as side effects of the drug. In the present investigation, carrier (lactose)-based dry-powder inhaler of rifampicin was prepared to achieve direct targeting of the drug into the lungs. METHODS:The dr...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1379

    authors: Rawal T,Kremer L,Halloum I,Butani S

    更新日期:2017-12-01 00:00:00

  • Pulmonary Toxicity of Benzalkonium Chloride.

    abstract::The available toxicity data of benzalkonium chloride (BKC) clearly shows that it is toxic; however, the weight of evidence favors the view that at doses encountered in nasally and orally inhaled pharmaceutical preparations it is well tolerated. The adverse toxicological data predominantly come from in vitro and animal...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,评审

    doi:10.1089/jamp.2017.1390

    authors: Johnson NF

    更新日期:2018-02-01 00:00:00

  • Deposition Mechanisms.

    abstract::The success of inhalation therapy is not only dependent upon the pharmacology of the drugs being inhaled but also upon the site and extent of deposition in the respiratory tract. Similarly, the toxicity of environmental and industrial particulate matter is affected not only by the nature of the dust but also by the am...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2020.29029.cd

    authors: Darquenne C

    更新日期:2020-08-01 00:00:00

  • Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions.

    abstract:BACKGROUND:Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide-formoterol (DuoResp) Spiromax; flow rates through empty versions of the Spiromax and T...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1216

    authors: Canonica GW,Arp J,Keegstra JR,Chrystyn H

    更新日期:2015-10-01 00:00:00

  • A New Quantitative Method for Evaluating Dry Powder Inhalation Efficiency in Asthma Patients.

    abstract:PURPOSE:Many methods have been developed to evaluate dry powder inhalation techniques and their efficiency for disease control in asthma patients. However, it is difficult to apply these methods to clinical practice and research. In this study, we introduce a simple new method that can be applied to dry powder inhalati...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2014.1193

    authors: Liang Y,Hu H,Tian C,Lei Y,Liu C,Luo F

    更新日期:2016-10-01 00:00:00

  • Collecting exhaled breath condensate (EBC) with two condensers in series: a promising technique for studying the mechanisms of EBC formation, and the volatility of selected biomarkers.

    abstract::Exhaled breath condensate (EBC) consists mainly of water, but also contains semivolatile and nonvolatile compounds. The aim of this study was to develop a system in which two condensers are simultaneously used in series to clarify the mechanisms of EBC condensation. Two aliquots of EBC (EBC1 and EBC2) were collected f...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2007.0644

    authors: Corradi M,Goldoni M,Caglieri A,Folesani G,Poli D,Corti M,Mutti A

    更新日期:2008-03-01 00:00:00

  • Use of a Remote Inhaler Monitoring Device to Measure Change in Inhaler Use with Chronic Obstructive Pulmonary Disease Exacerbations.

    abstract:BACKGROUND:Remote inhaler monitoring is an emerging technology that enables the healthcare team to monitor the time and location of a patient's inhaler use. We assessed the feasibility of remote inhaler monitoring for chronic obstructive pulmonary disease (COPD) patients and the pattern of albuterol inhaler use associa...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1383

    authors: Sumino K,Locke ER,Magzamen S,Gylys-Colwell I,Humblet O,Nguyen HQ,Thomas RM,Fan VS

    更新日期:2018-06-01 00:00:00

  • Assessment of the Power Required for Optimal Use of Current Inhalation Devices.

    abstract:: Background: Inhalation of medications is the cornerstone in the treatment of patients with lung diseases. A variety of inhalation devices exists and each device has specific requirements to achieve optimum inhalation of the drug. The goal of this study was to establish a c...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1376

    authors: Pohlmann G,Hohlfeld JM,Haidl P,Pankalla J,Cloes RM

    更新日期:2018-12-01 00:00:00

  • Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.

    abstract::Flexhaler is a multiple-dose, inspiratory flow-driven dry powder inhaler that is a newer version of Turbuhaler, and is identical to the Symbicort Turbuhaler. Sustained performance is of the utmost importance to ensure consistent drug delivery throughout the lifespan of the inhaler. We report functionality testing resu...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0700

    authors: Lööf T,Elfman P,Ström P,Törngren A,Borgström L

    更新日期:2008-12-01 00:00:00